Skip to main content
Erschienen in: BMC Cancer 1/2019

Open Access 01.12.2019 | Research article

Collagen organization of renal cell carcinoma differs between low and high grade tumors

verfasst von: Sara L. Best, Yuming Liu, Adib Keikhosravi, Cole R. Drifka, Kaitlin M. Woo, Guneet S. Mehta, Marie Altwegg, Terra N. Thimm, Matthew Houlihan, Jeremy S. Bredfeldt, E. Jason Abel, Wei Huang, Kevin W. Eliceiri

Erschienen in: BMC Cancer | Ausgabe 1/2019

Abstract

Background

The traditional pathologic grading for human renal cell carcinoma (RCC) has low concordance between biopsy and surgical specimen. There is a need to investigate adjunctive pathology technique that does not rely on the nuclear morphology that defines the traditional grading. Changes in collagen organization in the extracellular matrix have been linked to prognosis or grade in breast, ovarian, and pancreatic cancers, but collagen organization has never been correlated with RCC grade. In this study, we used Second Harmonic Generation (SHG) based imaging to quantify possible differences in collagen organization between high and low grades of human RCC.

Methods

A tissue microarray (TMA) was constructed from RCC tumor specimens. Each TMA core represents an individual patient. A 5 μm section from the TMA tissue was stained with standard hematoxylin and eosin (H&E). Bright field images of the H&E stained TMA were used to annotate representative RCC regions. In this study, 70 grade 1 cores and 51 grade 4 cores were imaged on a custom-built forward SHG microscope, and images were analyzed using established software tools to automatically extract and quantify collagen fibers for alignment and density assessment. A linear mixed-effects model with random intercepts to account for the within-patient correlation was created to compare grade 1 vs. grade 4 measurements and the statistical tests were two-sided.

Results

Both collagen density and alignment differed significantly between RCC grade 1 and RCC grade 4. Specifically, collagen fiber density was greater in grade 4 than in grade 1 RCC (p < 0.001). Collagen fibers were also more aligned in grade 4 compared to grade 1 (p < 0.001).

Conclusions

Collagen density and alignment were shown to be significantly higher in RCC grade 4 vs. grade 1. This technique of biopsy sampling by SHG could complement classical tumor grading approaches. Furthermore it might allow biopsies to be more clinically relevant by informing diagnostics. Future studies are required to investigate the functional role of collagen organization in RCC.
Abkürzungen
CT
computerized tomography
H&E
hematoxylin and eosin
RCC
human renal cell carcinoma
RMB
renal mass biopsy
ROI
Region of Interest
SHG
Second Harmonic Generation
TACS
tumor-associated collagen signature
TMA
tissue microarray
UW
University of Wisconsin

Background

The incidence of renal cell carcinoma (RCC) has been rising, largely due to the incidental detection of asymptomatic kidney tumors on cross-sectional imaging studies such as computerized tomography (CT) scans [1, 2]. Many of these tumors are small and behave in an indolent fashion, regardless of a malignant histology. Additionally, renal tumors are often more prevalent in elderly populations or patients with comorbidities that make surgical extirpation less desirable.
These clinical concerns have led to increased interest in using renal mass biopsy (RMB) to identify lesions of different metastatic potentials in an effort to tailor treatment to the individual patient. While RMB is accurate for distinguishing malignant from benign masses, biopsy may frequently misestimate tumor grade [38]. This inaccuracy is problematic because RCC grade is a strong predictor of tumor behavior and whether patients will develop metastatic disease [9]. Improving the ability to accurately assign tumor grade from RMB samples could greatly help counsel patients about the risks and benefits of treatment.
The pathologic grading of many cancers, including renal, is traditionally based on features of cytological atypia of epithelial cells. Evidence in other cancers such as breast has shown that the tumor stroma also plays a vital role in tumor progression [10, 11]. As such, it follows that stromal features may also be used as biomarkers for tumor aggressiveness. In particular, collagen deposition and rearrangement in the stroma have been linked to non-renal cancer progression with cancer cells being shown to migrate along collagen “scaffolds” in vivo [12]. While the collagen patterns in RCC have not been well described to date, optical detection of collagen changes has been demonstrated in a number of cancers including ovarian, breast, pancreatic, and esophageal and linked to important clinical parameters [10, 11, 1319].
While collagen and other stromal features can be identified with a variety of stains and standard white light microscopy, these techniques often lack quantitative measures, require special stains, and typically limit interpretation to “subjective” analysis by a pathologist. More recently applied advanced microscopy techniques, however, harness the native physical properties of the tissues to generate high-resolution images, suitable for quantitative image analysis. One such optical technique, Second Harmonic Generation (SHG) [14], is label free, provides optical sectioning, high signal to noise data, and is specific to fibrillar collagen. SHG has been used to study a wide spectrum of diseases accompanied by fibrosis, ranging from different kinds of cancer to atherosclerosis, by providing quantitative information about collagen changes [1013, 15, 16, 2029]. While there has been previous application of SHG to distinguish benign and malignant renal tumors [30], SHG based assessment of collagen organization in different grades of RCC has not been previously reported. To that end, we set out to characterize and quantify collagen changes in high and low grade RCC tissues that have different nuclear features but have never been compared in terms of collagen fiber based features.
To summarize, as the traditional pathologic grading for human RCC has low concordance between biopsy and surgical specimen [38], there is a need to investigate adjunctive pathology technique that does not rely on the nuclear morphology that defines the traditional grading. Changes in collagen organization in the extracellular matrix have been linked to prognosis or grade in breast [10], ovarian [13, 19], and pancreatic [15] cancers, but collagen organization has never been correlated with RCC grade. In this study, we used SHG based imaging to quantify possible differences in collagen organization between high and low grades of human RCC.

Methods

Human RCC microarray slide preparation

A human RCC tissue microarray (TMA) block was constructed by the Translational Research Initiatives in Pathology lab at the University of Wisconsin-Madison (UW-Madison). A section of 5um thickness was cut from the TMA block containing ~600um diameter tissue TMA cores. The spots (cores) were taken from surgical resection (partial or total nephrectomy) specimens. Each core was taken from its representative tumor grade area. Since each core is rather small (0.6 mm in diameter), the tumor grade of each core was homogenous. The section was then placed on a glass slide, stained with standard hematoxylin and eosin (H&E), and mounted under a #1.5 glass coverslip. Different tissue cores were from different patients.

Histological imaging and region of interest (ROI) annotation

A bright field image of the entire H&E slide was collected with an Aperio CS2 Digital Pathology Scanner (Leica Biosystems) at 20× magnification. Each core of grade 1 and grade 4 was cropped to the size of 1520 pixels by 1520 pixels using Aperio ImageScope viewing software (Leica Biosystems). An expert in genitourinary pathology reviewed the cropped cores to re-confirm the grade information and selected the representative regions containing cancer cells and an adjacent stroma region with patterns consistent with Fuhrman grade the whole tumor had been categorized as. For each core, 2–3 ROIs with the size of 400 pixels by 400 pixels (202um by 202um) were annotated containing typical cancer cells of grade 1 or grade 4 while excluding confounding tissue features (i.e. adipose tissue, benign tissue). In total, 75 TMA cores were verified and annotated as grade 1 clear cell RCC and 55 TMA cores as grade 4 clear cell RCC. Each core represents an individual patient. As described below in the SHG imaging methods section, nine total cores were excluded for lack of signal.

SHG imaging

All cores in this study were imaged with a custom built forward detection SHG microscope utilized previously [31, 32]. A MIRA 900 Ti: Sapphire laser (Coherent, Santa Clara, CA) was used to deliver 780 nm light to the sample using a 40×/1.25NA water immersion objective (Nikon, Melville, NY). Forward channel light was collected using a 1.2 NA condenser (Nikon, Melville, NY) and the SHG signal was filtered with a bandpass filter specific for the collagen signal at 780 nm (390/18 BP, Semrock) and collected with a H7422–40P GaAsP photomultiplier tube (Hamamatsu, Hamamatsu, Japan). Circular polarization was implemented and verified for the SHG light source. All of the cores were imaged with consistent power settings as a montage of 1024 pixel by 1024 pixel image tiles using in house developed acquisition software (http://​loci.​wisc.​edu/​software/​wiscscan). No SHG signal was observed for five grade 1 cores and four grade 4 cores after navigating the system to at least 3 different fields of view on each core. Hence those 9 cores were excluded. Seventy grade 1 cores and 51 grade 4 cores with SHG signal were imaged and analyzed in this study.

Image and statistical analysis

The image tiles of each core were stitched according to image metadata to create a whole core image using Fiji [33]. To locate the annotated ROIs on the SHG images, the corresponding H&E bright field images of each core were first registered with the SHG images using a combined method of color based segmentation via K-means clustering and iterative intensity-based registration implemented in MATLAB (R2014b, The MathWorks Inc., Natick, MA). The ROIs might present a minor shift from the original ROI region during the image registration and ROI transformation. The automatic registration failed in one core due to the weak collagen signal in that core, and that core was manually registered using a Fiji plugin “landmark correspondences”. The pathologist confirmed that the registration process did not alter any clinically relevant image features.
Cropped SHG images were then analyzed using an open-source fiber analysis software tool named CT-FIRE (https://​loci.​wisc.​edu/​software/​ctfire) [34] as well as other MATLAB (R2014b, The MathWorks Inc., Natick, MA) scripts and R [35] scripts. Collagen density and collagen alignment were calculated for each core and compared between grade 1 and grade 4 based on collagen fibers extracted by CT-FIRE. Collagen fibers that were longer than 5.3 μm (or 30 pixels) were counted as valid fibers in this study. This 5.3u threshold was determined by a qualitative assessment. Collagen density was calculated as the number of fibers in each ROI. Collagen alignment was a measure of the similarity of the orientations of collagen fibers in a given image, calculated as the mean resultant vector length in circular statistics [36]. The alignment coefficient ranged from 0.0 to 1.0, where larger alignment coefficients indicate fibers in a given image are more aligned. For this fiber based collagen alignment analysis, the number of fibers in an ROI was found to need at least 20 fibers to yield statistically reasonable results. This requirement led to the exclusion of some of the cores with very few collagen fibers. Hence, in collagen alignment analysis, the sample size was reduced and was smaller than that used in collagen density analysis.
Summary statistics were calculated for measurements across all ROIs. To compare grade 1 vs. grade 4 measurements, a separate linear mixed-effects model with random intercepts to account for the within-patient correlation (due to multiple measurements from different ROIs per patient) was created for the dependent variables of collagen density and collagen alignment. Each collagen feature was the outcome of interest, and grade 4 vs. grade 1 was the predictor variable. Statistical tests were two-sided, and the level of significance was set at (p < 0.05). All statistical analysis was done in R 3.3.1 [35] including the “nlme” package.

Results

The Curvelet transform-based image analysis software utilized (CT-FIRE) is capable of quantifying a number of collagen fiber characteristics. CT-FIRE accurately quantified RCC collagen fiber alignment and density based on manual review of CT-FIRE output images with the extracted fibers overlaid on the original SHG image. For this investigation, we focused our analysis on collagen density and alignment, since these were the most apparent differences noted between specimens on subjective assessment. Figure 1 shows two representative bright field and SHG images from grade 1 and grade 4, respectively, that indicate RCC grade 1 and RCC grade 4 have significantly different collagen alignment.
Collagen density was found to be significantly lower in grade 1 RCC compared to grade 4 (p < 0.001) as shown in Fig. 2, with a density increase of 68.98 for grade 4 RCC (95% confidence interval 30.76–107.20).
Significant differences in collagen alignment were also found between grade 1 RCC and grade 4 RCC (p < 0.001) as shown in Fig. 3. Collagen fibers appeared more aligned in RCC grade 4 compared to RCC grade 1, with an increase of 0.092 (95% confidence interval0.044–0.141). Parallel “bundles” of collagen fibers were detected in many samples of RCC grade 4.

Discussion

The increased incidence of small renal masses (SRMs) has placed a significant burden upon patients and the medical community as a whole as clinicians struggle to predict which patients would benefit from treatment of their lesions. It is already accepted that not all patients require surgical extirpation of their renal tumors, but the pathways to making that decision are currently ill defined. Tumor size and growth patterns have been advocated as possible metrics, but low metastatic-potential lesions may be relatively large at diagnosis and a number of studies have demonstrated tumor growth kinetics do not reliably differentiate benign and malignant lesions [37, 38].
Many experts have promoted utilizing RMB to assist in risk stratification [4, 6]. Percutaneous tumor biopsy is appealing due to its low morbidity [4, 39, 40]. While core biopsy can be very useful in separating benign from malignant renal masses, the biopsy accuracy for tumor grade is unfortunately limited. For example, Neuzillet and colleagues [3] found core biopsies to be only 69.8% accurate in determining Fuhrman grade when biopsy pathology reports were compared to surgical specimens. Additionally, Halverson et al. [6] reported that 32 out of 72 patients diagnosed with low-grade clear cell RCC on biopsy who ultimately underwent surgical tumor removal were actually found to have high-grade RCC on final pathology, suggesting an unmet need to predict tumor aggressiveness from small biopsy specimens with increased accuracy. The concordance can be increased if two-tier grading system (e.g. low grades (1,2) vs grades (3, 4)) is used as reported by Millet et al. [5]. However, the level of improvement is case-specific and it remains challenging in more accurate grading between individual grades in low and high grades such as differentiating grade 2 and 3 that is clinically important. This inaccuracy in grading is likely multifactorial and related to challenges in Fuhrman grading, interobserver variations, and most importantly, the tumor grade heterogeneity associated with RCC itself [4].
While collagen characteristics of RCC are not well described, collagen patterning has been linked to tumor behavior and clinical factors in other malignancies. SHG microscopy has already shown promise in studying other cancers, including breast [10], ovarian [13, 19], pancreas [15], and prostate [4143]. For example, SHG data have been used to differentiate different types of benign and malignant tissues [14, 15]. Keely and colleagues [11, 44] have done extensive work characterizing the collagen patterning associated with breast cancer using SHG, showing that collagen fibers become aligned perpendicular to the tumor boundary in the invasive phase of disease. This “tumor-associated collagen signature” (TACS-3) can serve as an optical biomarker to independently predict breast cancer patient survival [10, 31].
Our current study determined that there are significant differences in both collagen density and fiber alignment between grade 1 and grade 4 RCC. Collagen density comparison from fiber-based analysis shown in Fig. 2 is in agreement with collagen intensity based analysis (quantitation of white pixel percentage to total pixel number), indicating number of collagen fibers and collagen percentage carry similar density-related information in this study. It is particularly compelling that collagen fibers appeared more aligned in RCC grade 4 compared to RCC grade 1 (p < 0.001). The prevalence of parallel collagen fibers in high grade RCC is interesting since in other non-renal malignancies, tumor cells have been observed to invade surrounding tissues along aligned collagen fibers [11, 12, 45]. Breast cancer cells have even demonstrated the ability to reorganize collagen fibers in a random collagen matrix to facilitate invasion [11]. The ability of malignancies to organize a collagen “scaffold” may represent an important step in tumorigenesis, and while this active process has not yet been investigated in kidney cancer, it is fascinating to find the greatest collagen alignment in the most aggressive of RCCs. However, the current two collagen features cannot be directly used as diagnostic tools as both features if used alone lack the applicable discriminant ability. It is our hope that future investigations of advanced imaging methods such as SHG, which does not rely on the nuclear morphology that defines the Fuhrman system, may show that this adjunctive pathology technology can improve our characterization of predicted tumor behavior. More studies are needed to determine if/how collagen features could be of help for clinical decision making.
It should be noted that we qualitatively observed that the collagen organization appears to be highly heterogeneous across different cores of a same grade and across different regions of the same core. This observation led us to consult with an expert in genitourinary pathology for specific ROI annotation. Manual ROI annotation improves the accuracy of the grading assignment and makes the comparison between different grades focus on the prominent extracellular matrix features of the RCC tumor at a given grade. Benign tissue was not included in this study as benign tissue is already reliably identified with current techniques and there has already been at least one publication showing the SHG based collagen differences between benign and malignant renal tumor [30].
Our investigation has several limitations that need to be addressed in future studies. First, the sample size is relatively limited and focused on determining differences in collagen patterning between the “extremes” of kidney cancer, low and high grade RCC. Future studies will evaluate the SHG signals generated by grade 2 and 3 clear cell, as well as other renal neoplasms such as papillary RCC and other RCC subtypes. Additionally, RCC is known for its intratumor heterogeneity, which contributes to nuclear grade inaccuracy on RMB specimens and we also observed great heterogeneity of collagen distribution in TMA cores of the same Fuhrman grade. Some cores present very weak collagen signal while many others have strong signals. Whether collagen patterns are more homogeneous throughout a tumor than nuclear features (and thus less sensitive to sampling error) remains yet to be determined. One focus of the future investigations would be sampling larger tumor areas with different Fuhrman grades of the same patient to access how collagen features can possibly help overcome the heterogeneity issue. Finally, as the samples in the microarray were randomly oriented on the slide, we were not able to assess collagen alignment with respect to the tumor margin with the surrounding normal kidney. To quantify the relative alignment, a bigger area of a tissue section rather than just TMAs needs to be imaged and the tumor boundaries could then be annotated and analyzed following the work flow described in our previous work [31].

Conclusions

While differences in collagen patterning can be visualized subjectively, an advantage of our methodology is that the use of SHG to identify collagen fibers in a sample permits automatic digital image processing and quantification and can be applied to unstained tissues including fresh tissue. From a clinical standpoint, SHG is also a highly flexible platform, able to image unstained tissue (fresh, frozen, or fixed) slides already produced as part of the standard pathology workflow. Additionally, the ability to study tissues with SHG in vivo including in live animal models, such has been previously described in breast cancer, may shed significant light on the functional role of collagen in relation to the behavior of RCC tumors. Finally, despite the limited number of the TMA cores in our investigation, we found significant differences in collagen alignment and density. This is important clinically, due to the nature of the current “problem” facing physicians counseling RCC patients before treatment: a need for more reliable biopsy-based biomarkers with which to advise patients about the malignant potential of their tumors. Future studies will seek to assess if SHG optical biomarkers of collagen alignment and density can improve accurate determination of RCC tumor grade from biopsy specimens and aid patient counseling about cancer prognosis.

Acknowledgements

We would like to thank Dr. Jens Eickhoff of the Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, for his advice on the statistical analysis.

Funding

This study was supported by the UW Department of Urology with additional funding from the UW Laboratory for Optical and Computational Instrumentation. We acknowledge funding support from the UW Institute for Clinical and Translational Research (ICTR) under award #UL1TR000427. We also acknowledge funding from NIH under grants R01 CA179556 (KWE) and U54DK104310 (KWE). The authors thank the UW Translational Research Initiatives in Pathology Laboratory, in part supported by the UW Department of Pathology and Laboratory Medicine and UWCCC grant P30 CA014520, for use of its facilities and services.

Availability of data and materials

The datasets generated and/or analysed during the current study are available in the MINDS@UW repository, http://​digital.​library.​wisc.​edu/​1793/​77866
Not applicable.
Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Nepple KG, Yang L, Grubb RL, Strope SA. Population based analysis of the increasing incidence of kidney cancer in the United States: evaluation of age specific trends from 1975 to 2006. J Urol. 2012;187:32–8.CrossRef Nepple KG, Yang L, Grubb RL, Strope SA. Population based analysis of the increasing incidence of kidney cancer in the United States: evaluation of age specific trends from 1975 to 2006. J Urol. 2012;187:32–8.CrossRef
2.
Zurück zum Zitat Volpe A, Cadeddu JA, Cestari A, Gill IS, Jewett MAS, Joniau S, et al. Contemporary Management of Small Renal Masses. Eur Urol. 2011;60:501–15.CrossRef Volpe A, Cadeddu JA, Cestari A, Gill IS, Jewett MAS, Joniau S, et al. Contemporary Management of Small Renal Masses. Eur Urol. 2011;60:501–15.CrossRef
3.
Zurück zum Zitat Neuzillet Y, Lechevallier E, Andre M, Daniel L, Coulange C. Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol. 2004;171:1802–5.CrossRef Neuzillet Y, Lechevallier E, Andre M, Daniel L, Coulange C. Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol. 2004;171:1802–5.CrossRef
4.
Zurück zum Zitat Volpe A, Finelli A, Gill IS, Jewett MAS, Martignoni G, Polascik TJ, et al. Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol. 2012;62:491–504.CrossRef Volpe A, Finelli A, Gill IS, Jewett MAS, Martignoni G, Polascik TJ, et al. Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol. 2012;62:491–504.CrossRef
5.
Zurück zum Zitat Millet I, Curros F, Serre I, Taourel P, Thuret R. Can renal biopsy accurately predict histological subtype and Fuhrman grade of renal cell carcinoma? J Urol. 2012;188:1690–4.CrossRef Millet I, Curros F, Serre I, Taourel P, Thuret R. Can renal biopsy accurately predict histological subtype and Fuhrman grade of renal cell carcinoma? J Urol. 2012;188:1690–4.CrossRef
6.
Zurück zum Zitat Halverson SJ, Kunju LP, Bhalla R, Gadzinski AJ, Alderman M, Miller DC, et al. Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology. J Urol. 2013;189:441–6.CrossRef Halverson SJ, Kunju LP, Bhalla R, Gadzinski AJ, Alderman M, Miller DC, et al. Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology. J Urol. 2013;189:441–6.CrossRef
7.
Zurück zum Zitat Marconi L, Dabestani S, Lam TB, Hofmann F, Stewart F, Norrie J, et al. Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol. 2016;69:660–73.CrossRef Marconi L, Dabestani S, Lam TB, Hofmann F, Stewart F, Norrie J, et al. Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol. 2016;69:660–73.CrossRef
8.
Zurück zum Zitat Patel HD, Johnson MH, Pierorazio PM, Sozio SM, Sharma R, Iyoha E, et al. Diagnostic accuracy and risks of biopsy in the diagnosis of a renal mass suspicious for localized renal cell carcinoma: systematic review of the literature. J Urol. 2016;195:1340–7.CrossRef Patel HD, Johnson MH, Pierorazio PM, Sozio SM, Sharma R, Iyoha E, et al. Diagnostic accuracy and risks of biopsy in the diagnosis of a renal mass suspicious for localized renal cell carcinoma: systematic review of the literature. J Urol. 2016;195:1340–7.CrossRef
9.
Zurück zum Zitat Fuhrman SAMD, Lasky LCMD, Limas CMD. Prognostic significance of morphologic parameters in renal cell carcinoma. J Surg Pathol. 1982;6:655–64.CrossRef Fuhrman SAMD, Lasky LCMD, Limas CMD. Prognostic significance of morphologic parameters in renal cell carcinoma. J Surg Pathol. 1982;6:655–64.CrossRef
10.
Zurück zum Zitat Conklin MW, Eickhoff JC, Riching KM, Pehlke CA, Eliceiri KW, Provenzano PP, et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol. 2011;178:1221–32.CrossRef Conklin MW, Eickhoff JC, Riching KM, Pehlke CA, Eliceiri KW, Provenzano PP, et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol. 2011;178:1221–32.CrossRef
11.
Zurück zum Zitat Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 2006;4:38.CrossRef Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 2006;4:38.CrossRef
12.
Zurück zum Zitat Sahai E, Wyckoff J, Philippar U, Segall JE, Gertler F, Condeelis J. Simultaneous imaging of GFP, CFP and collagen in tumors in vivo using multiphoton microscopy. BMC Biotechnol. 2005;5:14.CrossRef Sahai E, Wyckoff J, Philippar U, Segall JE, Gertler F, Condeelis J. Simultaneous imaging of GFP, CFP and collagen in tumors in vivo using multiphoton microscopy. BMC Biotechnol. 2005;5:14.CrossRef
13.
Zurück zum Zitat Nadiarnykh O, LaComb RB, Brewer MA, Campagnola PJ. Alterations of the extracellular matrix in ovarian cancer studied by second harmonic generation imaging microscopy. BMC Cancer. 2010;10:94.CrossRef Nadiarnykh O, LaComb RB, Brewer MA, Campagnola PJ. Alterations of the extracellular matrix in ovarian cancer studied by second harmonic generation imaging microscopy. BMC Cancer. 2010;10:94.CrossRef
14.
Zurück zum Zitat Campagnola P. Second harmonic generation imaging microscopy: applications to diseases diagnostics. Anal Chem. 2011;83:3224–31.CrossRef Campagnola P. Second harmonic generation imaging microscopy: applications to diseases diagnostics. Anal Chem. 2011;83:3224–31.CrossRef
16.
Zurück zum Zitat Hanley CJ, Noble F, Ward M, Bullock M, Drifka C, Mellone M, et al. A subset of myofibroblastic cancer-associated fibroblasts regulate collagen fiber elongation, which is prognostic in multiple cancers. Oncotarget. 2015;7:6159–74.PubMedCentral Hanley CJ, Noble F, Ward M, Bullock M, Drifka C, Mellone M, et al. A subset of myofibroblastic cancer-associated fibroblasts regulate collagen fiber elongation, which is prognostic in multiple cancers. Oncotarget. 2015;7:6159–74.PubMedCentral
17.
Zurück zum Zitat Keikhosravi A, Bredfeldt JS, Sagar AK, Eliceiri KW. Second-harmonic generation imaging of cancer. Methods Cell Biol. 2014;123:531–46.CrossRef Keikhosravi A, Bredfeldt JS, Sagar AK, Eliceiri KW. Second-harmonic generation imaging of cancer. Methods Cell Biol. 2014;123:531–46.CrossRef
18.
Zurück zum Zitat Perry SW, Burke RM, Brown EB. Two-photon and second harmonic microscopy in clinical and translational cancer research. Ann Biomed Eng. 2012;40:277–91.CrossRef Perry SW, Burke RM, Brown EB. Two-photon and second harmonic microscopy in clinical and translational cancer research. Ann Biomed Eng. 2012;40:277–91.CrossRef
19.
Zurück zum Zitat Wen B, Campbell KR, Tilbury K, Nadiarnykh O, Brewer MA, Patankar M, et al. 3D texture analysis for classification of second harmonic generation images of human ovarian cancer. Sci Rep. 2016;6:35734.CrossRef Wen B, Campbell KR, Tilbury K, Nadiarnykh O, Brewer MA, Patankar M, et al. 3D texture analysis for classification of second harmonic generation images of human ovarian cancer. Sci Rep. 2016;6:35734.CrossRef
20.
Zurück zum Zitat Ajeti V, Nadiarnykh O, Ponik SM, Keely PJ, Eliceiri KW, Campagnola PJ. Structural changes in mixed col I/col V collagen gels probed by SHG microscopy: implications for probing stromal alterations in human breast cancer. Biomed Opt Express. 2011;2:2307–16.CrossRef Ajeti V, Nadiarnykh O, Ponik SM, Keely PJ, Eliceiri KW, Campagnola PJ. Structural changes in mixed col I/col V collagen gels probed by SHG microscopy: implications for probing stromal alterations in human breast cancer. Biomed Opt Express. 2011;2:2307–16.CrossRef
21.
Zurück zum Zitat Han M, Giese G, Bille JF. Second harmonic generation imaging of collagen fibrils in cornea and sclera. Opt Express. 2005;13:5791–7.CrossRef Han M, Giese G, Bille JF. Second harmonic generation imaging of collagen fibrils in cornea and sclera. Opt Express. 2005;13:5791–7.CrossRef
22.
Zurück zum Zitat Kwon GP, Schroeder JL, Amar MJ, Remaley AT, Balaban RS. Contribution of macromolecular structure to the retention of low-density lipoprotein at arterial branch points. Circulation. 2008;117:2919–27.CrossRef Kwon GP, Schroeder JL, Amar MJ, Remaley AT, Balaban RS. Contribution of macromolecular structure to the retention of low-density lipoprotein at arterial branch points. Circulation. 2008;117:2919–27.CrossRef
23.
Zurück zum Zitat Kirkpatrick ND, Brewer MA, Utzinger U. Endogenous optical biomarkers of ovarian cancer evaluated with multiphoton microscopy. Cancer Epidemiol Prev Biomark. 2007;16:2048–57.CrossRef Kirkpatrick ND, Brewer MA, Utzinger U. Endogenous optical biomarkers of ovarian cancer evaluated with multiphoton microscopy. Cancer Epidemiol Prev Biomark. 2007;16:2048–57.CrossRef
24.
Zurück zum Zitat LaComb R, Nadiarnykh O, Campagnola PJ. Quantitative second harmonic generation imaging of the diseased state osteogenesis imperfecta: experiment and simulation. Biophys J. 2008;94:4504–14.CrossRef LaComb R, Nadiarnykh O, Campagnola PJ. Quantitative second harmonic generation imaging of the diseased state osteogenesis imperfecta: experiment and simulation. Biophys J. 2008;94:4504–14.CrossRef
25.
Zurück zum Zitat Le TT, Langohr IM, Locker MJ, Sturek M, Cheng J-X. Label-free molecular imaging of atherosclerotic lesions using multimodal nonlinear optical microscopy. J Biomed Opt. 2007;12:054007.CrossRef Le TT, Langohr IM, Locker MJ, Sturek M, Cheng J-X. Label-free molecular imaging of atherosclerotic lesions using multimodal nonlinear optical microscopy. J Biomed Opt. 2007;12:054007.CrossRef
26.
Zurück zum Zitat Lin S-J, Wu R Jr, Tan H-Y, Lo W, Lin W-C, Young T-H, et al. Evaluating cutaneous photoaging by use of multiphoton fluorescence and second-harmonic generation microscopy. Opt Lett. 2005;30:2275–7.CrossRef Lin S-J, Wu R Jr, Tan H-Y, Lo W, Lin W-C, Young T-H, et al. Evaluating cutaneous photoaging by use of multiphoton fluorescence and second-harmonic generation microscopy. Opt Lett. 2005;30:2275–7.CrossRef
27.
Zurück zum Zitat Lo W, Teng S-W, Tan H-Y, Kim KH, Chen H-C, Lee H-S, et al. Intact corneal stroma visualization of GFP mouse revealed by multiphoton imaging. Microsc Res Tech. 2006;69:973–5.CrossRef Lo W, Teng S-W, Tan H-Y, Kim KH, Chen H-C, Lee H-S, et al. Intact corneal stroma visualization of GFP mouse revealed by multiphoton imaging. Microsc Res Tech. 2006;69:973–5.CrossRef
28.
Zurück zum Zitat Strupler M, Pena A-M, Hernest M, Tharaux P-L, Martin J-L, Beaurepaire E, et al. Second harmonic imaging and scoring of collagen in fibrotic tissues. Opt Express. 2007;15:4054–65.CrossRef Strupler M, Pena A-M, Hernest M, Tharaux P-L, Martin J-L, Beaurepaire E, et al. Second harmonic imaging and scoring of collagen in fibrotic tissues. Opt Express. 2007;15:4054–65.CrossRef
29.
Zurück zum Zitat Sun W, Chang S, Tai DCS, Tan N, Xiao G, Tang H, et al. Nonlinear optical microscopy: use of second harmonic generation and two-photon microscopy for automated quantitative liver fibrosis studies. J Biomed Opt. 2008;13:064010–064010–7.CrossRef Sun W, Chang S, Tai DCS, Tan N, Xiao G, Tang H, et al. Nonlinear optical microscopy: use of second harmonic generation and two-photon microscopy for automated quantitative liver fibrosis studies. J Biomed Opt. 2008;13:064010–064010–7.CrossRef
30.
Zurück zum Zitat Galli R, Sablinskas V, Dasevicius D, Laurinavicius A, Jankevicius F, Koch E, et al. Non-linear optical microscopy of kidney tumours. J Biophotonics. 2014;7:23–7.CrossRef Galli R, Sablinskas V, Dasevicius D, Laurinavicius A, Jankevicius F, Koch E, et al. Non-linear optical microscopy of kidney tumours. J Biophotonics. 2014;7:23–7.CrossRef
32.
Zurück zum Zitat Keikhosravi A, Liu Y, Drifka C, Woo KM, Verma A, Oldenbourg R, et al. Quantification of collagen organization in histopathology samples using liquid crystal based polarization microscopy. Biomed Opt Express. 2017;8:4243–56.CrossRef Keikhosravi A, Liu Y, Drifka C, Woo KM, Verma A, Oldenbourg R, et al. Quantification of collagen organization in histopathology samples using liquid crystal based polarization microscopy. Biomed Opt Express. 2017;8:4243–56.CrossRef
33.
Zurück zum Zitat Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676–82.CrossRef Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676–82.CrossRef
34.
Zurück zum Zitat Bredfeldt JS, Liu Y, Pehlke CA, Conklin MW, Szulczewski JM, Inman DR, et al. Computational segmentation of collagen fibers from second-harmonic generation images of breast cancer. J Biomed Opt. 2014;19:–016007. Bredfeldt JS, Liu Y, Pehlke CA, Conklin MW, Szulczewski JM, Inman DR, et al. Computational segmentation of collagen fibers from second-harmonic generation images of breast cancer. J Biomed Opt. 2014;19:–016007.
37.
Zurück zum Zitat Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DYT, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175:425–31.CrossRef Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DYT, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175:425–31.CrossRef
38.
Zurück zum Zitat Kunkle DA, Crispen PL, Chen DYT, Greenberg RE, Uzzo RG. Enhancing renal masses with zero net growth during active surveillance. J Urol. 2007;177:849–53 discussion 853-854.CrossRef Kunkle DA, Crispen PL, Chen DYT, Greenberg RE, Uzzo RG. Enhancing renal masses with zero net growth during active surveillance. J Urol. 2007;177:849–53 discussion 853-854.CrossRef
39.
Zurück zum Zitat Leveridge MJ, Finelli A, Kachura JR, Evans A, Chung H, Shiff DA, et al. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol. 2011;60:578–84.CrossRef Leveridge MJ, Finelli A, Kachura JR, Evans A, Chung H, Shiff DA, et al. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol. 2011;60:578–84.CrossRef
40.
Zurück zum Zitat Prince J, Bultman E, Hinshaw L, Drewry A, Blute M, Best S, et al. Patient and tumor characteristics can predict nondiagnostic renal mass biopsy findings. J Urol. 2015;193:1899–904.CrossRef Prince J, Bultman E, Hinshaw L, Drewry A, Blute M, Best S, et al. Patient and tumor characteristics can predict nondiagnostic renal mass biopsy findings. J Urol. 2015;193:1899–904.CrossRef
41.
Zurück zum Zitat Huang Y, Zhuang Z. Second harmonic microscopic imaging and spectroscopic characterization in prostate pathological tissue. Scanning. 2013;:n/a–n/a. Huang Y, Zhuang Z. Second harmonic microscopic imaging and spectroscopic characterization in prostate pathological tissue. Scanning. 2013;:n/a–n/a.
42.
Zurück zum Zitat Rai S, Srivastava A, Sooriakumaran P, Tewari A. Advances in imaging the neurovascular bundle. Curr Opin Urol. 2012;22:88–96.CrossRef Rai S, Srivastava A, Sooriakumaran P, Tewari A. Advances in imaging the neurovascular bundle. Curr Opin Urol. 2012;22:88–96.CrossRef
43.
Zurück zum Zitat Zheng-Fei Z, Han-Ping L, Zhou-Yi G, Shuang-Mu Z, Bi-Ying Y, Xiao-Yuan D. Second-harmonic generation as a DNA malignancy indicator of prostate glandular epithelial cells. Chin Phys B. 2010;19:049501.CrossRef Zheng-Fei Z, Han-Ping L, Zhou-Yi G, Shuang-Mu Z, Bi-Ying Y, Xiao-Yuan D. Second-harmonic generation as a DNA malignancy indicator of prostate glandular epithelial cells. Chin Phys B. 2010;19:049501.CrossRef
44.
Zurück zum Zitat Provenzano PP, Inman DR, Eliceiri KW, Knittel JG, Yan L, Rueden CT, et al. Collagen density promotes mammary tumor initiation and progression. BMC Med. 2008;6:11.CrossRef Provenzano PP, Inman DR, Eliceiri KW, Knittel JG, Yan L, Rueden CT, et al. Collagen density promotes mammary tumor initiation and progression. BMC Med. 2008;6:11.CrossRef
45.
Zurück zum Zitat Wyckoff JB, Wang Y, Lin EY, Li J, Goswami S, Stanley ER, et al. Direct visualization of macrophage-assisted tumor cell Intravasation in mammary tumors. Cancer Res. 2007;67:2649–56.CrossRef Wyckoff JB, Wang Y, Lin EY, Li J, Goswami S, Stanley ER, et al. Direct visualization of macrophage-assisted tumor cell Intravasation in mammary tumors. Cancer Res. 2007;67:2649–56.CrossRef
Metadaten
Titel
Collagen organization of renal cell carcinoma differs between low and high grade tumors
verfasst von
Sara L. Best
Yuming Liu
Adib Keikhosravi
Cole R. Drifka
Kaitlin M. Woo
Guneet S. Mehta
Marie Altwegg
Terra N. Thimm
Matthew Houlihan
Jeremy S. Bredfeldt
E. Jason Abel
Wei Huang
Kevin W. Eliceiri
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Cancer / Ausgabe 1/2019
Elektronische ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-5708-z

Weitere Artikel der Ausgabe 1/2019

BMC Cancer 1/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.